- In February 2024, GE HealthCare launched the LOGIQ ultrasound portfolio, including the LOGIQ Totus, offering high-quality imaging and AI-powered diagnostic support to improve precision in point of care diagnostics
- In April 2024, Abbott's i-STAT TBI cartridge was approved for use with whole blood, enhancing rapid traumatic brain injury diagnostics at the point of care
- In January 2024, Rutgers University developed the CytoTracker Leukometer, a device that rapidly counts white blood cells from a single blood drop, aiding in swift sepsis detection and chemotherapy management
- In February 2022, Sense Biodetection entered into a strategic agreement with Una Health (Una) for the United Kingdom distribution of the Veros Covid-19 test
- In December 2021, FIND invested USD 21 million in Biomeme, Bioneer, Qlife, and SD Biosensor to accelerate the development, manufacturing, and launch of affordable point-of-care molecular diagnostic platforms that can detect multiple pathogens that cause diseases including COVID-19
